Literature DB >> 17237445

Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus.

Yansong Li1, Tatsuhiro Harada, Yuang-Taung Juang, Vasileios C Kyttaris, Ying Wang, Michael Zidanic, Kenneth Tung, George C Tsokos.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune/inflammatory disease characterized by autoantibody production and abnormal T cells that infiltrate tissues through not well-known mechanisms. We report that SLE T lymphocytes display increased levels of CD44, ezrin, radixin, and moesin (ERM) phosphorylation, stronger actin polymerization, higher polar cap formation, and enhanced adhesion and chemotactic migration compared with T cells from patients with rheumatoid arthritis and normal individuals. Silencing of CD44 by CD44 small interfering RNA in SLE T cells inhibited significantly their ability to adhere and migrate as did treatment with Rho kinase and actin polymerization inhibitors. Forced expression of T567D-ezrin, a phosphorylation-mimic form, enhanced remarkably the adhesion and migration rate of normal T cells. Anti-CD3/TCR autoantibodies present in SLE sera caused increased ERM phosphorylation, adhesion, and migration in normal T cells. pERM and CD44 are highly expressed in T cells infiltrating in the kidneys of patients with lupus nephritis. These data prove that increased ERM phosphorylation represents a key molecular abnormality that guides T cell adhesion and migration in SLE patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237445     DOI: 10.4049/jimmunol.178.3.1938

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

Review 2.  Novel Treatments in Lupus.

Authors:  Vasileios C Kyttaris
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

Review 3.  Establishment and maintenance of cell polarity during leukocyte chemotaxis.

Authors:  Concepción Gómez-Moutón; Santos Mañes
Journal:  Cell Adh Migr       Date:  2007-04-06       Impact factor: 3.405

4.  T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis.

Authors:  Robert A Cohen; George Bayliss; Jose C Crispin; Gwen F Kane-Wanger; Christine A Van Beek; Vasileios C Kyttaris; Ingrid Avalos; C Yung Yu; George C Tsokos; Isaac E Stillman
Journal:  Clin Immunol       Date:  2008-07       Impact factor: 3.969

5.  Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane.

Authors:  Daniel Canals; Russell W Jenkins; Patrick Roddy; María José Hernández-Corbacho; Lina M Obeid; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

Review 6.  Targeting lymphocyte signaling pathways as a therapeutic approach to systemic lupus erythematosus.

Authors:  Vasileios C Kyttaris; George C Tsokos
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

7.  Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.

Authors:  José C Crispín; Mohamed Oukka; George Bayliss; Robert A Cohen; Christine A Van Beek; Isaac E Stillman; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice.

Authors:  Colin Edgerton; José C Crispín; Chantal M Moratz; Estelle Bettelli; Mohamed Oukka; Milomir Simovic; Athina Zacharia; Ryan Egan; Jie Chen; Jurandir J Dalle Lucca; Yuang-Taung Juang; George C Tsokos
Journal:  Clin Immunol       Date:  2008-12-05       Impact factor: 3.969

Review 9.  Small molecules in the treatment of systemic lupus erythematosus.

Authors:  Anastasia Markopoulou; Vasileios C Kyttaris
Journal:  Clin Immunol       Date:  2012-10-02       Impact factor: 3.969

10.  A RhoA and Rnd3 cycle regulates actin reassembly during membrane blebbing.

Authors:  Kana Aoki; Fumiyo Maeda; Tomoya Nagasako; Yuki Mochizuki; Seiichi Uchida; Junichi Ikenouchi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.